Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Common and unrecognized, primary aldosteronism warrants more screening, targeted treatment Regina Schaffer
-
- Bempedoic acid lowers LDL regardless of glycemic status Darlene Dobkowski, MA
- Certain drugs may promote unintentional weight gain in postmenopausal women Michael Monostra
- Filling prescriptions becomes easier for some, harder for others during COVID-19 Regina Schaffer
- Increase in DKA at diabetes diagnosis shows delays in medical care during pandemic Regina Schaffer
- Preparation, technology key to managing diabetes in schools during pandemic Michael Monostra
- Prevalence of diabetes, hypertension among COVID-19 patients likely lower than reported Michael Monostra
- Rare obesity disorders call for genetic testing, targeted therapies Robert M. Haws, MD
- Antidepressants elevate risk for type 2 diabetes Regina Schaffer
-
- Early type 2 diabetes diagnosis drives long-term kidney disease risk Regina Schaffer
- Guidance for pituitary disease management during COVID-19 Regina Schaffer
- Mild obesity doubles risk for respiratory failure in COVID-19 Regina Schaffer
- Statin use may lead to ‘unintended consequence’ of insulin resistance Regina Schaffer
- Testosterone therapy associated with type 2 diabetes remission in men with hypogonadism Regina Schaffer
- TSH variations in pregnancy could prompt erroneous subclinical thyroid disease diagnosis Regina Schaffer
- REDUCE-IT DIABETES: Icosapent ethyl lowers CV event risk in type 2 diabetes Regina Schaffer
- The ‘cardiometabolic dilemma’: Collaboration across specialties advances diabetes research Regina Schaffer
-
- Should adrenal vein sampling be the test for surgical management of primary aldosteronism?